Cargando…
Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders
The aim of this study was to evaluate the expression of the senescence markers, Decoy Receptor 2 (DcR2) and Differentiated Embryo-Chondrocyte expressed gen 1 (DEC1), in oral potentially malignant disorders (OPMDs) to ascertain their possible association with oral cancer risk. The immunohistochemical...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531848/ https://www.ncbi.nlm.nih.gov/pubmed/37762685 http://dx.doi.org/10.3390/ijms241814382 |
_version_ | 1785111816626503680 |
---|---|
author | de Villalaín, Lucas Álvarez-Teijeiro, Saúl Rodríguez-Santamarta, Tania Fernández del Valle, Álvaro Allonca, Eva Rodrigo, Juan P. de Vicente, Juan Carlos García-Pedrero, Juana M. |
author_facet | de Villalaín, Lucas Álvarez-Teijeiro, Saúl Rodríguez-Santamarta, Tania Fernández del Valle, Álvaro Allonca, Eva Rodrigo, Juan P. de Vicente, Juan Carlos García-Pedrero, Juana M. |
author_sort | de Villalaín, Lucas |
collection | PubMed |
description | The aim of this study was to evaluate the expression of the senescence markers, Decoy Receptor 2 (DcR2) and Differentiated Embryo-Chondrocyte expressed gen 1 (DEC1), in oral potentially malignant disorders (OPMDs) to ascertain their possible association with oral cancer risk. The immunohistochemical analysis of DcR2 and DEC1 expression (along with p16 and Ki67 expression) was carried out in 60 patients with clinically diagnosed oral leukoplakia. Fifteen cases (25%) subsequently developed an invasive carcinoma. Correlations between protein marker expression, histological grade and oral cancer risk were assessed. DcR2, DEC1 and Ki67 protein expressions were found to correlate significantly with increased oral cancer risk, and also with an increased grade of dysplasia. Multivariate analysis demonstrated that DcR2 and Ki67 expression are independent predictors of oral cancer development. Our results evidence for the first time the potential of DcR2 as an early biomarker to assess oral cancer risk in patients with oral leukoplakia (HR = 59.7, p = 0.015), showing a superior predictive value to histology (HR = 4.225, p = 0.08). These findings reveal that the increased expression of DcR2 and DEC1 occurred frequently in OPMDs. In addition, DcR2 expression emerges as a powerful biomarker for oral cancer risk assessment in patients with oral leukoplakia. |
format | Online Article Text |
id | pubmed-10531848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105318482023-09-28 Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders de Villalaín, Lucas Álvarez-Teijeiro, Saúl Rodríguez-Santamarta, Tania Fernández del Valle, Álvaro Allonca, Eva Rodrigo, Juan P. de Vicente, Juan Carlos García-Pedrero, Juana M. Int J Mol Sci Article The aim of this study was to evaluate the expression of the senescence markers, Decoy Receptor 2 (DcR2) and Differentiated Embryo-Chondrocyte expressed gen 1 (DEC1), in oral potentially malignant disorders (OPMDs) to ascertain their possible association with oral cancer risk. The immunohistochemical analysis of DcR2 and DEC1 expression (along with p16 and Ki67 expression) was carried out in 60 patients with clinically diagnosed oral leukoplakia. Fifteen cases (25%) subsequently developed an invasive carcinoma. Correlations between protein marker expression, histological grade and oral cancer risk were assessed. DcR2, DEC1 and Ki67 protein expressions were found to correlate significantly with increased oral cancer risk, and also with an increased grade of dysplasia. Multivariate analysis demonstrated that DcR2 and Ki67 expression are independent predictors of oral cancer development. Our results evidence for the first time the potential of DcR2 as an early biomarker to assess oral cancer risk in patients with oral leukoplakia (HR = 59.7, p = 0.015), showing a superior predictive value to histology (HR = 4.225, p = 0.08). These findings reveal that the increased expression of DcR2 and DEC1 occurred frequently in OPMDs. In addition, DcR2 expression emerges as a powerful biomarker for oral cancer risk assessment in patients with oral leukoplakia. MDPI 2023-09-21 /pmc/articles/PMC10531848/ /pubmed/37762685 http://dx.doi.org/10.3390/ijms241814382 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article de Villalaín, Lucas Álvarez-Teijeiro, Saúl Rodríguez-Santamarta, Tania Fernández del Valle, Álvaro Allonca, Eva Rodrigo, Juan P. de Vicente, Juan Carlos García-Pedrero, Juana M. Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders |
title | Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders |
title_full | Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders |
title_fullStr | Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders |
title_full_unstemmed | Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders |
title_short | Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders |
title_sort | emerging role of decoy receptor-2 as a cancer risk predictor in oral potentially malignant disorders |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531848/ https://www.ncbi.nlm.nih.gov/pubmed/37762685 http://dx.doi.org/10.3390/ijms241814382 |
work_keys_str_mv | AT devillalainlucas emergingroleofdecoyreceptor2asacancerriskpredictorinoralpotentiallymalignantdisorders AT alvarezteijeirosaul emergingroleofdecoyreceptor2asacancerriskpredictorinoralpotentiallymalignantdisorders AT rodriguezsantamartatania emergingroleofdecoyreceptor2asacancerriskpredictorinoralpotentiallymalignantdisorders AT fernandezdelvallealvaro emergingroleofdecoyreceptor2asacancerriskpredictorinoralpotentiallymalignantdisorders AT alloncaeva emergingroleofdecoyreceptor2asacancerriskpredictorinoralpotentiallymalignantdisorders AT rodrigojuanp emergingroleofdecoyreceptor2asacancerriskpredictorinoralpotentiallymalignantdisorders AT devicentejuancarlos emergingroleofdecoyreceptor2asacancerriskpredictorinoralpotentiallymalignantdisorders AT garciapedrerojuanam emergingroleofdecoyreceptor2asacancerriskpredictorinoralpotentiallymalignantdisorders |